Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (14897)	11/22/1999 1:20:00 PM
From: Kevin Clarke	Respond to of 150070

* BIG NEWS OUT FOR APPI * Related Quotes APPI.OB 0.057500 +0.005000 delayed 20 mins - disclaimer Monday November 22, 12:43 pm Eastern Time Company Press Release SOURCE: Advanced Plant Pharmaceuticals, Inc. Advanced Plant Pharmaceuticals Inc. - APPI - Kinray Inc. Agrees to Distribute APPI Products to 700 Independent Pharmacies NEW YORK, Nov. 22 /PRNewswire/ -- Advanced Plant Pharmaceuticals, Inc. (OTC Bulletin Board: APPI - news) a company that utilizes whole plants to develop all natural dietary supplements, is pleased to announce that they have reached an agreement in principle with Kinray Inc. where by Kinray will initially distribute APPI's products to over 700 independent pharmacies in New York metropolitan area. Kinray further agreed to distribute APPI products to an additional 1300 independent pharmacies throughout New Jersey, Connecticut, Pennsylvania, Rhode Island and Massachusetts representing the balance of Kinray's entire distribution network. Kinray, with sales currently in excess of one billion dollars, is the largest privately held wholesaler of pharmaceutical products and health & beauty aids in the United States, operating from only one facility. Kinray is #237 on Forbes Magazine's top 500 largest privately held Companies for 1998, #29 on Crains Business Magazine's annual top 200 privately-held companies in the New York tri-state area, and won the distinction of the #1 largest privately-held company in the four outer boroughs of New York at the 1999 Bridges to Success awards program. Kinray has enjoyed the reputation of the most successful pharmaceutical wholesale distributor in the northeast trading area. ``I'm thrilled to be working with a company such as Kinray, the combination of our unique products and Kinray's distribution efforts could lead to substantial revenues for our Company', stated David Lieberman, President and CEO of APPI. ``All we really need is the opportunity to get our products on the shelves of independent pharmacies and chain stores and let the product speak for itself, Kinray is giving us this opportunity. Kinray has a highly experienced management team and they are very capable of successfully launching our products on a regional level. We intend to support Kinray's efforts with a radio and print advertising campaign for the initial launch in the New York metropolitan area.' Mr. Lieberman further stated, ``We at APPI believe that the agreement in principle with Kinray will be the first step in penetrating the national dietary supplement market in the United States.' For more information on APPI, please visit the Company's Web site at advancedplantpharm.com. The company hopes to announce further agreements in the near future. APPI is a company that develops innovative plant formulations and technology for clinical application. APPI has met FDA nutritional specifications for the marketing of its Cholesterol lowering agent ``Lo-Chol' in the USA, and has received the first IND from the FDA for a whole plant pharmaceutical, Abavca/ACA, which has potential as an immunomodulater in the treatment of patients infected with HIV, the virus that causes AIDS. APPI's Whole Plant Pharmaceutical Grade Process is trade secret. Utilization of the APPI process converts a whole plant into a standardized product. APPI is in the on-going process of establishing exclusive distributorships for their products in the United States and abroad. This press release contains forward-looking statements. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Contact: Barry Clare of Advanced Plant Pharmaceuticals, Inc., 212-695-3334 SOURCE: Advanced Plant Pharmaceuticals, Inc. -------------------------------------------------------------------------------- More Quotes and News: Advanced Plant Pharmaceuticals Inc (OTC BB:APPI.OB - news)